A simplified scoring system to document variant patterns in nodular lymphocyte predominant Hodgkin lymphoma

References

• Poppema S, Delsol G, Pileri SA, et al. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Harris NL, Campo E, editors. WHO classification of tumours of hematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. pp 323–325.
   Google Scholar
• Diehl V, Sextro M, Franklin J, et al. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease. J Clin Oncol 1999;17:776–783.
   PubMed Web of Science ®Google Scholar
• Pellegrino B, Terrier-Lacombe MJ, Oberlin O, et al. Lymphocyte-predominant Hodgkin's lymphoma in children: therapeutic abstention after initial lymph node resection--a study of the French Society of Paediatric Oncology. J Clin Oncol 2003;15:2948–2952.
   Web of Science ®Google Scholar
• Advani RH, Hoppe RT. How I treat nodular lymphocyte predominant Hodgkin lymphoma. Blood 2013;122:4182–4188.
   PubMed Web of Science ®Google Scholar
• Hartmann S, Eichenauer DA, Plütschow A, et al. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG). Blood 2013;122:4246–4252.
   PubMed Web of Science ®Google Scholar
• Hawkes E, Wotherspoon A, Cunningham D. The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management. Leuk Lymphoma 2012;53:354–361.
   PubMed Web of Science ®Google Scholar
• Nogova L, Reineke T, Eich HT, et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin study Group (GHSG). Ann Oncol 2005;583:1683–1687.
   Web of Science ®Google Scholar
• Smith LB. Nodular lymphocyte predominant Hodgkin lymphoma: diagnostic pearls and pitfalls. Arch Pathol Lab Med 2010;134: 1434–1439.
   PubMed Web of Science ®Google Scholar
• Alavaikko MJ, Hansmann ML, Nebendahl C, et al. Follicular dendritic cells in Hodgkin's disease. Am J Clin Pathol 1991;95:194–200.
   PubMed Web of Science ®Google Scholar
• Boudova L, Torlakovic E, Delabie J, et al. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma. Blood 2003;102:3753–3758.
   PubMed Web of Science ®Google Scholar
• Fan Z, Natkunam Y, Bair E, et al. Characterization of variant patterns of nodular lymphocyte predominant Hodgkin lymphoma with immunohistologic and clinical correlation. Am J Surg Pathol 2003;27:1346–1356.
   PubMed Web of Science ®Google Scholar
• Al-Mansour M, Connors JM, Gascoyne RD, et al. Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma. J Clin Oncol 2010;28:793–799.
   PubMed Web of Science ®Google Scholar
• Wickert RS, Weisenburger DD, Tierens A, et al. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 1995;86:2312–2320.
   PubMed Web of Science ®Google Scholar
• Hansmann ML, Stein H, Fellbaum C, et al. Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. Hum Pathol 1989;20:1169–1175.
   PubMed Web of Science ®Google Scholar
• Huang JZ, Weisenburger DD, Vose JM, et al. Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group. Leuk Lymphoma 2004;45:1551–1557.
   PubMed Web of Science ®Google Scholar
• Rueffer U, Josting A, Franklin J, et al. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment and prognosis. J Clin Oncol 2001;19:2026–2032.
   PubMed Web of Science ®Google Scholar
• Fanale M. A novel prognostic scoring system for NLPHL. Blood. 2013;122:4154–4155.
   PubMed Web of Science ®Google Scholar
• Poppema S, Kaiserling E, Lennert K. Hodgkin's disease with lymphocytic predominance, nodular type (nodular paragranuloma) and progressively transformed germinal centres--a cytohistological study. Histopathology. 1979;3:295–308.
   PubMed Web of Science ®Google Scholar
• Burns BF, Colby TV, Dorfman RF. Differential diagnostic features of nodular L & H Hodgkin's disease, including progressive transformation of germinal centers. Am J Surg Pathol. 1984;8:253–61.
   PubMed Web of Science ®Google Scholar
• Mason DY, Banks PM, Chan J, et al. Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity. Am J Surg Pathol 1994;18:526–30.
   PubMed Web of Science ®Google Scholar
• von Wasielewski R, Werner M, Fischer R, et al. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group. Am J Pathol. 1997;150:793–803.
   PubMed Web of Science ®Google Scholar
• Nam-Cha SH, Roncador G, Sanchez-Verde L, et al. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma. Am J SurgPathol. 2008;32:1252–7.
   Web of Science ®Google Scholar
• Churchill HR, Roncador G, Warnke RA, Natkunam Y. Programmed death 1 expression in variant immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma: comparison with CD57 and lymphomas in the differential diagnosis. Human Pathol. 2010;41, 1726–34.
   PubMed Web of Science ®Google Scholar
• Rüdiger T, Gascoyne RD, Jaffe ES, et al. Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell/histiocyte-rich B cell lymphoma. Ann Oncol. 2002;13 Suppl 1:44–51.
   PubMed Web of Science ®Google Scholar
• Nogová L, Reineke T, Brillant C, et al; German Hodgkin Study Group. Lymphocyte- predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group. J Clin Oncol. 2008;26: 434–39.
   PubMed Web of Science ®Google Scholar
• Nogová L, Reineke T, Eich HT, et al;Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA ymphocyte-predominant Hodgkin's lymphoma: A retrospective analysis from the German Hodgkin study Group (GHSG). Ann Oncol 2005;583-1683–87,
   Google Scholar
• Nogová L, Rudiger T, Engert A. Biology, clinical course and management of nodular lymphocyte-predominant Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program. 2006: 266–72.
   Google Scholar